Abstract:Photodynamic therapy (PDT) can be developed into an important arsenal against cancer; it is a minimally invasive therapy, which is used in the treatment or/and palliation of a variety of cancers and benign diseases. The removal of cancerous tissue is achieved with the use of photosensitizer and a light source, which excites the photosensitizer. This excitation causes the photosensitizer to generate singlet oxygen and other reactive oxygen species. PDT has been used in several types of cancers including nonmelanoma skin cancer, bladder cancer, esophageal cancer, head and neck cancer, and non-small cell lung cancer (NSCLC). Although it is routinely used in nonmelanoma skin cancer, it has not been widely adopted in other solid cancers due to a lack of clinical data showing the superiority of PDT over other forms of treatment. Singlet oxygen used in PDT can alter the activity of the catalase, which induces immunomodulation through HOCl signaling. The singlet oxygen can induce apoptosis through both the extrinsic and intrinsic pathways. The extrinsic pathway of apoptosis starts with the activation of the Fas receptor by singlet oxygen that leads to activation of the caspase-7 and caspase-3. In the case of the intrinsic pathway, disruption caused by singlet oxygen in the mitochondria membrane leads to the release of cytochrome c, which binds with APAF-1 and procaspase-9, forming a complex, which activates caspase-3. Mechanisms of PDT action can vary according to organelles affected. In the plasma membrane, membrane disruption is caused by the oxidative stress leading to the intake of calcium ions, which causes swelling and rupture of cells due to excess intake of water, whereas disruption of lysosome causes the release of the cathepsins B and D, which cleave Bid into tBid, which changes the mitochondrial outer membrane permeability (MOMP). Oxidative stress causes misfolding of protein in the endoplasmic reticulum. When misfolding exceeds the threshold, it triggers unfolding protein response (UPR), which leads to activation of caspase-9 and caspase-3. Finally, the activation of p38 MAPK works as an alternative pathway for the induction of MOMP.

A New Insight into the Singlet Oxygen Mechanism for Photodynamic Therapy

Singlet Oxygen in Photodynamic Therapy

New Cyclometalated Transition-Metal Based Photosensitizers for Singlet Oxygen Generation and Photodynamic Therapy

Two-Dimensional Singlet Oxygen Imaging with Its Near-Infrared Luminescence During Photosensitization

Recent progress in the development of singlet oxygen carriers for enhanced photodynamic therapy

Determination of Singlet Oxygen Quantum Yield Based on the Behavior of Solvent Dimethyl Sulfoxide Oxidation by Singlet Oxygen

Generation of singlet oxygen inside living cells: correlation between phosphorescence decay lifetime, localization and outcome of photodynamic action

Deciphering Oxygen‐Independent Augmented Photodynamic Oncotherapy by Facilitating the Separation of Electron‐Hole Pairs

Metalloporphyrin–indomethacin conjugates as new photosensitizers for photodynamic therapy

Progress in Porphyrins As a Photosensitizing Drug for Photodynamic Therapy

Strategies to construct efficient singlet oxygen-generating photosensitizers

Targeted Endoperoxides Delivering Singlet Oxygen to Cancer Cell Mitochondria: Exploration of the Therapeutic Potential

A singlet oxygen-storing covalent organic framework for "Afterglow" photodynamic therapy

Supramolecular Photosensitizer Enables Oxygen-Independent Generation of Hydroxyl Radicals for Photodynamic Therapy.

Photosensitizer-Singlet Oxygen Sensor Conjugated Silica Nanoparticles for Photodynamic Therapy and Bioimaging

Photo‐Triggered Fluorescence Polyelectrolyte Nanoassemblies: Manipulate and Boost Singlet Oxygen in Photodynamic Therapy

Oxygen Concentration Effect in Photosensitized Generation of 1 O 2 from Normoxia to Hypoxia

First-principles design of heavy-atom-free singlet oxygen photosensitizers for photodynamic therapy

Singlet Oxygen, Photodynamic Therapy, and Mechanisms of Cancer Cell Death

A Novel Theranostic Nanoprobe for in Vivo Singlet Oxygen Detection and Real-Time Dose-Effect Relationship Monitoring in Photodynamic Therapy

An unexpected strategy to alleviate hypoxia limitation of photodynamic therapy by biotinylation of photosensitizers